Top

Reactions Weekly

Published in:

01-04-2024 | Erlotinib | Case report

Erlotinib

Lack of drug effect

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Country of occurrence, reporter country and primary source country not stated. Author's communication details not available.

Di Ieva A, et al. Thyrotropin secreting pituitary microadenoma and lung adenocarcinoma treated with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) Erlotinib and Osimertinib: a case report. Journal of the Endocrine Society 6 (Suppl.): A513-A514, Dec 2022. Available from: URL: https://dx.doi.org/10.1210/jendso/bvac150.1068 [abstract]

Title: Erlotinib
Lack of drug effect
Publication date: 01-04-2024
Publisher: Springer International Publishing
Keywords: Erlotinib
Hyperthyroidism
Pituitary Adenoma
Osimertinib
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-56837-2

2024 ASCO Annual Meeting

Springer Medicine

Erlotinib

Lack of drug effect

Excerpt

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Amphotericin-B-liposomal/flucytosine

Ceftriaxone

Prilocaine

Pioglitazone/Rosiglitazone

Rivaroxaban

Sirolimus/Steroids